Dass-127

The original instrument, the , was constructed by S.H. Lovibond and P.F. Lovibond in 1995. Unlike many other scales that rely heavily on somatic symptoms (like sleep disturbances or appetite changes), which can be confounded by physical illness, the DASS focuses on the psychological and affective core of the disorders.

The discovery of new therapeutic agents with enhanced efficacy and reduced side effects is a significant goal in pharmaceutical research. This study focuses on the synthesis, characterization, and biological evaluation of a novel compound, DASS-127. Our research indicates that DASS-127 exhibits potent anti-inflammatory properties, making it a promising candidate for the development of new treatments for inflammatory diseases. DASS-127